EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H26N4O |
| Net Charge | 0 |
| Average Mass | 386.499 |
| Monoisotopic Mass | 386.21066 |
| SMILES | Cc1ccccc1CN1C(=O)C2=C(CCN(Cc3ccccc3)C2)N2CCN=C12 |
| InChI | InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-23(29)21-17-26(15-19-8-3-2-4-9-19)13-11-22(21)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3 |
| InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | dopamine receptor D2 antagonist An antagonist that binds to and deactivates the dopamine receptor D2, the main receptor for all antipsychotic drugs. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| dordaviprone (CHEBI:232328) has role antineoplastic agent (CHEBI:35610) |
| dordaviprone (CHEBI:232328) has role apoptosis inducer (CHEBI:68495) |
| dordaviprone (CHEBI:232328) has role dopamine receptor D2 antagonist (CHEBI:131787) |
| dordaviprone (CHEBI:232328) is a benzenes (CHEBI:22712) |
| dordaviprone (CHEBI:232328) is a organic heterotricyclic compound (CHEBI:26979) |
| dordaviprone (CHEBI:232328) is a toluenes (CHEBI:27024) |
| IUPAC Name |
|---|
| 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one |
| INNs | Source |
|---|---|
| dordaviprona | WHO MedNet |
| dordavipronum | WHO MedNet |
| dordaviprone | WHO MedNet |
| dordaviprone | WHO MedNet |
| Synonyms | Source |
|---|---|
| 11-benzyl-7-[(2-methylphenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one | SUBMITTER |
| ONC-201 | DrugBank |
| ONC 201 | SUBMITTER |
| ONC201 | DrugBank |
| TIC-10 | DrugBank |
| TIC10 | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| Dordaviprone | Wikipedia |
| DB14844 | DrugBank |
| D12733 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:1616632-77-9 | DrugBank |
| Citations |
|---|